<DOC>
	<DOCNO>NCT02993705</DOCNO>
	<brief_summary>Multicenter phase II study trabectedin patient advance uterine ovarian carcinosarcoma . Patients receive trabectedin disease progression unacceptable toxicity . Disease response evaluation assess every 9 week .</brief_summary>
	<brief_title>Trial On Trabectedin In The Treatment Of Advanced Uterine And Ovarian Carcinosarcoma ( CS ) _MITO 26</brief_title>
	<detailed_description>This Phase II , multi-centre , single arm study aim evaluate efficacy toxicity Trabectedin population advance recurrent ovarian uterine carcinosarcoma . Trabectedin infuse dose 1.3 mg/m2 3- hour iv infusion every 3 week via central venous catheter .</detailed_description>
	<mesh_term>Carcinosarcoma</mesh_term>
	<mesh_term>Mixed Tumor , Mullerian</mesh_term>
	<mesh_term>Trabectedin</mesh_term>
	<criteria>Histologically document Stage IIV recurrent uterine ovarian carcinosarcoma amenable surgery radiotherapy No 2 previous chemotherapy line PS 02 ( ECOG ) Age &gt; 18 Measurable disease Life expectancy least 3 month Adequate organ function : Hematopoietic ; Absolute neutrophil count ≥ 1,500/mm^3 ; Platelet count ≥ 100,000/mm^3 ; Hemoglobin ≥ 9 g/dL Hepatic ; AST ALT ≤ 1.5 time upper limit normal ( ULN ) * ; Protocol Version 1.0_05.09.2016 6 Alkaline phosphatase ≤ 2.5 time ULN* ; Bilirubin ≤ 1.5 time ULN NOTE : * ≤ 3 time ULN liver metastases present Renal ; Creatinine Clearance ≥ 45 mL/min Serum Creatinine ≤1.5 x ULN Serum Albumin &gt; 3.0 g/dL Previous Brachytherapy treatment uterine carcinosarcoma allow No invasive malignancy within past 3 year except nonmelanoma skin cancer Written Informed Consent More 2 previous chemotherapy line Single tumor lesion inside previous irradiate file Pregnant ( potentially fertile patient must pregnancy least 3 month study participation must negative serum pregnancy test ) Active infection require antibiotic Symptomatic peripheral neuropathy &gt; grade 2 accord NCI Common Toxicity Criteria . Congestive heart failure angina pectoris even medically control . Previous history myocardial infarction within 1 year study entry , uncontrolled high risk hypertension arrhythmia . Unstable severe intercurrent medical condition , opinion investigator , might interfere achievement study objectives Psychological sociological condition , addictive disorder , family problem , would preclude compliance protocol</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>